title: Primary Toxoplasma gondii infection in a pregnant human immunodeficiency virus-infected woman.
abstract: We report a 36-year-old HIV-infected woman who developed primary Toxoplasma gondii infection during pregnancy that was treated with spiramycin and antiretroviral drugs. There was no vertical transmission of toxoplasmosis and HIV.
authors.affiliation: National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS Clinic Department, Rome, Italy.
authors.forename: Gianpiero
authors.initials: G
authors.lastname: D'Offizi
authors.forename: Simone
authors.initials: S
authors.lastname: Topino
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Anzidei
authors.forename: Daniela
authors.initials: D
authors.lastname: Frigiotti
authors.forename: Pasquale
authors.initials: P
authors.lastname: Narciso
mesh_terms: D000328:Adult; D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis* / Q000188:drug therapy; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D018566:Pregnancy, High-Risk; D018570:Risk Assessment; D015572:Spiramycin / Q000008:administration & dosage; D014122:Toxoplasma / Q000302:isolation & purification*; D014123:Toxoplasmosis / Q000175:diagnosis* / Q000188:drug therapy; D014125:Toxoplasmosis, Congenital / Q000517:prevention & control*
chemical_list: D019380:Anti-HIV Agents; D015572:Spiramycin